| DELAWARE                                      |   | 33-0824714                                |
|-----------------------------------------------|--------|-------------------------------------------|
| (State      of jurisdiction of Incorporation) |   | (I.R.S.      Employer Identification No.) |
|                                          |   |                                      |
| 8885      REHCO RD. SAN DIEGO, CA        |   | 92121                                     |
| (Address      of principal executive offices) |   | (Zip      Code)                           |

|                                         |                                           |
|----------------------------------------------|------------------------------------------------|
| Title      of Each Classto be so Registered: | Name of each exchange on which      registered |
| None                                         | None                                           |

----

|                                                |                                                                                                                                                                                                                     |                                                                                                                               |
|-----------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------|
| Large      Accelerated Filer ¨                 |                                      | Accelerated      Filer                      ¨ |
| Non-accelerated      Filer    ¨ |                                                                                                                                                                                                                     | Smaller      reporting company þ                                                                                              |

----

| · | dependence      on key personnel;                           |
|--------|-------------------------------------------------------------|
| · | competitive      factors;                                   |
| · | degree      of success of research and development programs |
| · | the      operation of our business; and                     |
| · | general      economic conditions                            |

----

----

----

----

| (a)   | Providing  biospecimen      depository services , namely offering cryopreservation of cellular      specimens as well as laboratory processing of cellular      specimens  and |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (b)   | Through      Entest, our majority owned subsidiary, developing and commercializing      therapies, medical devices and medical testing  procedures. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

----

|   | 1. | Biologic      products, |
|--------|----|-------------------------|

|   | 2. | Medical      devices, |
|--------|----|-----------------------|

|   | 3. | Human      cells, tissues, cellular and tissue-based  products. |
|--------|----|-----------------------------------------------------------------|

----

----

| October      1, 2007 to September 30, 2008 | High | Low |
|--------------------------------------------|------|-----|
| First      Quarter                         | .40  | .10 |
| Second      Quarter                        | .63  | .11 |
| Third      Quarter                         | 1.29 | .35 |
| Fourth      Quarter                        | 1.02 | .20 |

| October      1, 2008 to September 30, 2009 | High | Low |
|--------------------------------------------|------|-----|
| First      Quarter                         | .73  | .15 |
| Second      Quarter                        | .40  | .15 |
| Third      Quarter                         | .24  | .06 |
| Fourth      Quarter                        | .15  | .07 |

----

----

| (a)   | the      sale of  equity securities of the Company and its subsidiary      generating cash proceeds of    approximately  $347,916 |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------|

| (b)   | Net      borrowings of approximately$285,863 |
|-----------------|----------------------------------------------|

----

|    |   |
|--------------|--------|

| (a)   | the      sale of equity securities of the company generating cash proceeds of      approximately $808,885 |
|-----------------|-----------------------------------------------------------------------------------------------------------|

| (b)   | Net      borrowings  of approximately$573,251 |
|-----------------|---------------------------------------------------------|

| (c)   | Issuance      of  Note to related party as consideration for purchase of      marketable securities valued at$500,000 |
|-----------------|---------------------------------------------------------------------------------------------------------------------------------|

----

----

| BIO-MATRIX      SCIENTIFIC GROUP, INC. AND SUBSIDIARIES                                                                                                                                                                                                                                                                                               |   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
| (A      Development Stage Company)                                                                                                                                                                                                                                                                                                                    |   |
| Consolidated      Balance Sheet                                                                                                                                                                                                                                                                                                                       |   |
| for      the year ended September 30,                                                                                                                                                                                                                                                                                                                 |   |
|                                                                                                                                                                                                                                                                                                                                                  |   |   |   |   |   |   |
|                                                                                                                                                                                                                                                                                                                                                  |   |   |   |   |   |   |
|                                                                                                                                                                                                                                                                                                                                                  |   |   |   |   |   |   |
|                                                                                                                                                                                                                                                                                                                                                  |   | 2009 |   |   | 2008 |   |
|                                                                                                                                                                                                                                                                                                                                                  |   |   |   |   |   |   |
|                                                                                                                                                                                                                                                                                                                                             |   |   |   |   |   |   |
| ASSETS                                                                                                                                                                                                                                                                                                                                                |   |
|                                                                                                                                                                                                                                                                                                                                             |   |   |   |   |   |   |
|  CURRENT      ASSETS                                                                                                                                                                                                                                                                                                                             |   |   |   |   |   |   |
| Cash                                                                                                                                                                                                                                                                                                                                                  |   | $ | 17,750 |   |   | $ | 8,410 |   |
| Securities      Available for sale                                                                                                                                                                                                                                                                                                                    |   |   | - |   |   |   | 550,000 |   |
| Pre-paid      Expenses                                                                                                                                                                                                                                                                                                                                |   |   | 333,398 |   |   |   | 49,258 |   |
|                                                                                                                                                                                                                                                                                                                                                  |   |   |   |   |   |   |   |   |
|      Total      Current Assets                                                                                                                                                                                                                                                                                               |   |   | 351,148 |   |   |   | 607,668 |   |
|                                                                                                                                                                                                                                                                                                                                             |   |   |   |   |   |   |   |   |
| PROPERTY      & EQUIPMENT (Net of      Accumulated       Depreciation)                                                                                                                                                                                                                                         |   |   | 538,868 |   |   |   | 538,868 |   |
|                                                                                                                                                                                                                                                                                                                                                  |   |   |   |   |   |   |   |   |
| Other      Assets                                                                                                                                                                                                                                                                                                                                     |   |   | 25,507 |   |   |   | 21,307 |   |
|                                                                                                                                                                                                                                                                                                                                                  |   |   |   |   |   |   |   |   |
|                                                                                                                                                                                                                                                                                                                                                  |   |   |   |   |   |   |   |   |
| TOTAL      ASSETS                                                                                                                                                                                                                                                                                                                                     |   | $ | 915,523 |   |   | $ | 1,167,843 |   |
|                                                                                                                                                                                                                                                                                                                                             |   |   |   |   |   |   |   |   |
|                                                                                                                                                                                                                                                                                                                                             |   |   |   |   |   |   |   |   |
|                                                   LIABILITIES      AND STOCKHOLDERS' EQUITY |   |   |   |   |   |   |   |   |
|                                                                                                                                                                                                                                                                                                                                             |   |   |   |   |   |   |   |   |
|                                                                                                                                                                                                                                                                                                                                             |   |   |   |   |   |   |   |   |
|  CURRENT      LIABILITIES                                                                                                                                                                                                                                                                                                                        |   |   |   |   |   |   |   |   |
| Accounts      payable                                                                                                                                                                                                                                                                                                                                 |   | $ | 227,377 |   |   | $ | 89,974 |   |
| Notes      Payable                                                                                                                                                                                                                                                                                                                                    |   |   | 397,322 |   |   |   | 111,459 |   |
| Accrued      Payroll                                                                                                                                                                                                                                                                                                                                  |   |   | 342,000 |   |   |   | 150,000 |   |
| Accrued      Payroll  taxes                                                                                                                                                                                                                                                                                                                 |   |   | 24,044 |   |   |   | 29,998 |   |
| Accrued      Interest                                                                                                                                                                                                                                                                                                                                 |   |   | 84,911 |   |   |   | 24,323 |   |
| Accrued      expenses                                                                                                                                                                                                                                                                                                                                 |   |   | 5,000 |   |   |   | 30,000 |   |
| Current      portion of Convertible Note                                                                                                                                                                                                                                                                                                              |   |   | 503,400 |   |   |   | - |   |
| Current      portion of Note to Affiliated Party                                                                                                                                                                                                                                                                                                      |   |   | 1,000 |   |   |   | - |   |
|           Total      Current Liabilities                                                                                                                                                                                                                                                            |   |   | 1,585,054 |   |   |   | 435,754 |   |
|                                                                                                                                                                                                                                                                                                                                             |   |   |   |   |   |   |   |   |
|  LONG      TERM LIABILITIES                                                                                                                                                                                                                                                                                                                      |   |   |   |   |   |   |   |   |
| Convertible      Note                                                                                                                                                                                                                                                                                                                                 |   |   | - |   |   |   | 503,400 |   |
| Note      to Affiliated Party                                                                                                                                                                                                                                                                                                                         |   |   | - |   |   |   | 500,000 |   |
|                                                                                                                                                                                                                                                                                                                                             |   |   |   |   |   |   |   |   |
|  TOTAL      LIABILITIES                                                                                                                                                                                                                                                                                                                          |   |   | 1,585,054 |   |   |   | 1,439,154 |   |
|                                                                                                                                                                                                                                                                                                                                             |   |   |   |   |   |   |   |   |
|  STOCKHOLDERS'      EQUITY                                                                                                                                                                                                                                                                                                                       |   |   |   |   |   |   |   |   |
| Preferred      Stock ($.0001 par value)                                                                                                                                                                                                                                                                                                               |   |   |   |   |   |   |   |   |
| 20,000,000      shares authorized; 5,668,547 and 2,975,478                                                                                                                                                                                                                                                                                            |   |   |   |   |   |   |   |   |
| issued      and outstanding as of September 30, 2008 and                                                                                                                                                                                                                                                                                              |   |   |   |   |   |   |   |   |
| September      30, 2009                                                                                                                                                                                                                                                                                                                               |   |   | 300 |   |   |   | 567 |   |
| Series      AA Preferred Stock ($0.0001 par value)                                                                                                                                                                                                                                                                                                    |   |   |   |   |   |   |   |   |
| 100,000      shares authorized; 4,852 issued and outstanding                                                                                                                                                                                                                                                                                          |   |   |   |   |   |   |   |   |
| as      of September 30, 2008 and September 30, 2009                                                                                                                                                                                                                                                                                                  |   |   |   |   |   |   |   |   |
| Series      B Preferred Shares ($0.0001 par value) 2,000,000 shares                                                                                                                                                                                                                                                                                   |   |   | 73 |   |   |   |   |   |
| authorized;      0 and  725, 409 issued and outstanding as of                                                                                                                                                                                                                                                                               |   |   |   |   |   |   |   |   |
| September      30, 2008 and September 30, 2009                                                                                                                                                                                                                                                                                                        |   |   |   |   |   |   |   |   |
| Common      Stock,  ($.0001  par value) 80,000,000      shares                                                                                                                                                                                                                                                                    |   |   |   |   |   |   |   |   |
| authorized;      24,870,867 and 43,728,375                                                                                                                                                                                                                                                                                                            |   |   |   |   |   |   |   |   |
| shares      issued and outstanding as of September 30, 2008 and                                                                                                                                                                                                                                                                                       |   |   |   |   |   |   |   |   |
| September      30, 2009                                                                                                                                                                                                                                                                                                                               |   |   | 4,371 |   |   |   | 2,488 |   |
| Additional      paid in Capital                                                                                                                                                                                                                                                                                                                       |   |   | 9,364,701 |   |   |   | 7,631,648 |   |
| Contributed      capital                                                                                                                                                                                                                                                                                                                              |   |   | 499,000 |   |   |   | - |   |
| Accumulated      Other Comprehensive Income (Loss)                                                                                                                                                                                                                                                                                                    |   |   | - |   |   |   | 50,000 |   |
| Deficit      accumulated during the development stage                                                                                                                                                                                                                                                                                                 |   |   | (10,443,980 | ) |   |   | (7,956,014 | ) |
| Deficit      attributable to noncontrolling interest in subsidiary                                                                                                                                                                                                                                                                                    |   |   | (93,995 | ) |   |   | - |   |
|                                                                                                                                                                                                                                                                                                                                             |   |   |   |   |   |   |   |   |
|       Total      Stockholders' Equity (Deficit)                                                                                                                                                                                                                                                                         |   |   | (669,530 | ) |   |   | (271,311 | ) |
|                                                                                                                                                                                                                                                                                                                                             |   |   |   |   |   |   |   |   |
|                                                                                                                                                                                                                                                                                                                                             |   |   |   |   |   |   |   |   |
|  TOTAL      LIABILITIES                                                                                                                                                                                                                                                                                                                          |   |   |   |   |   |   |   |   |
|  &      STOCKHOLDERS' EQUITY                                                                                                                                                                                                                                                                                                                 |   | $ | 915,523 |   |   | $ | 1,167,843 |   |

----

| BIO-MATRIX      SCIENTIFIC GROUP, INC. AND SUBSIDIARIES                                                                                                                                                                                |                                                                                                                                                                                   |                                                                                                                                                                                                                 |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (A      Development Stage Company)                                                                                                                                                                                                     |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| Consolidated      Statements of Operations                                                                                                                                                                                             |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
|                                                                                                                                                                                                                                   | Year      Ended                                                                                                                                                                        | Year      Ended                                                                                                                                                                                                      | From      Inception |   |   |
|                                                                                                                                                                                                                                   | September      30, 2009                                                                                                                                                                | September      30, 2008                                                                                                                                                                                              | (August      2, 2005) |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 | through |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 | September      30,2009 |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| REVENUES                                                                                                                                                                                                                               |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
|    Sales                                                                                                                                                                                                                |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
|  $                                     - | $                              - |  $                                  - |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| Total      Revenues                                                                                                                                                                                                                    | 0                                                                                                                                                                                      | 0                                                                                                                                                                                                                    | 0 |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| COSTS      AND EXPENSES                                                                                                                                                                                                                |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| Research      and Development                                                                                                                                                                                                          | 129,150                                                                                                                                                                                | 185,990                                                                                                                                                                                                              | 787,057 |   |   |
| General      and administrative                                                                                                                                                                                                        | 1,005,880                                                                                                                                                                              | 958,882                                                                                                                                                                                                              | 4,421,084 |   |   |
| Depreciation      and amortization                                                                                                                                                                                                     |                                                                                                                                                                                   | 453                                                                                                                                                                                                                  | 2,668 |   |   |
| Consulting      and professional fees                                                                                                                                                                                                  |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| 871,858                                                                                                                                                                                                                                | 1,875,666                                                                                                                                                                              | 4,630,390                                                                                                                                                                                                            |   |   |
| Impairment      of goodwill & intangibles                                                                                                                                                                                          |                                                                                                                                                                                   |                                                                                                                                                                                                                 | 34,688 |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| Total      Costs and Expenses                                                                                                                                                                                                          | 2,006,888                                                                                                                                                                              | 3,020,991                                                                                                                                                                                                            | 9,875,887 |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| OPERATING      LOSS                                                                                                                                                                                                                    |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| (2,006,888)                                                                                                                                                                                                                            | (3,020,991)                                                                                                                                                                            | (9,875,887)                                                                                                                                                                                                          |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| OTHER      INCOME & (EXPENSES)                                                                                                                                                                                                     |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| Interest      Expense                                                                                                                                                                                                                  |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| (117,080)                                                                                                                                                                                                                              | (61,183)                                                                                                                                                                               | (204,428)                                                                                                                                                                                                            |   |   |
| Interest      Income                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 | 306 |   |   |
| Other      income                                                                                                                                                                                                                      |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| 30,000                                                                                                                                                                                                                                 | 100                                                                                                                                                                                    | 30,100                                                                                                                                                                                                               |   |   |
| Loss      on sale of Available for Sale Securities                                                                                                                                                                                     | (487,900)                                                                                                                                                                              |                                                                                                                                                                                                                 | (487,900) |   |   |
| Other      Expense                                                                                                                                                                                                                     | (92)                                                                                                                                                                                   |                                                                                                                                                                                                                 | (166) |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| Total      Other Income & (Expenses)                                                                                                                                                                                               |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| (575,072)                                                                                                                                                                                                                              | (61,083)                                                                                                                                                                               | (662,088)                                                                                                                                                                                                            |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
|  NET      INCOME (LOSS)                                                                                                                                                                                                           |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |
|  $                  (2,581,960)                                                                                                         |  $               (3,082,074)                                                                           |  $             (10,537,975)                                                                                                                    |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| (NET      INCOME) LOSS attributable to                                                                                                                                                                                                 |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| noncontrolling      interest in Entest Biomedical, Inc                                                                                                                                                                                 | 93,995                                                                                                                                                                                 |                                                                                                                                                                                                                 | 93,995 |   |   |
|  Net      Loss attributable to common shareholders                                                                                                                                                                                |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
|  $                  (2,487,965)                                                                                                         |  $               (3,082,074)                                                                           |  $             (10,443,980)                                                                                                                    |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |
| BASIC      AND DILUTED EARNINGS (LOSS) PER SHARE                                                                                                                                                                                       |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |
| (0.076)                                                                                                                                                                                                                                | (0.12)                                                                                                                                                                                 |                                                                                                                                                                                                                 |   |   |
|                                                                                                                                                                                                                                   |                                                                                                                                                                                   |                                                                                                                                                                                                                 |   |   |   |
| Weighted      Average Shares Outstanding                                                                                                                                                                                               | 32,681,484                                                                                                                                                                             | 25,184,099                                                                                                                                                                                                           |   |   |   |

----

----

|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|--------|----------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             | Bio      Matrix Scientific Group, Inc. and Subsidiaries                                                                                                                                                                                                                  |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |
|   |                                                                             | (A      Development Stage Company)                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             | Consolidated      Statement of Cash Flow                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             | Inception      (August 2, 2005)  to                                                                                                                                                                             |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             | September      30, 2009                                                                                                                                                                                                   |   |
|   |                                                                             | Year      Ended September 30,2009                                                                                                                                                                                                                                        | Year      Ended September 30,2008                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | CASH      FLOWS FROM OPERATING ACTIVITIES                                        |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |  Net      Income (loss)                                                     |  $                                         (2,487,965) |  $                                             (3,082,074) |  $                                 (10,443,980) |   |
|   | Adjustments      to reconcile net loss to net cash (used in) provided            |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | by      operating activities:                                                    |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Depreciation      expense                                                        |                                                                                                                                                                                                                                                                     | 453                                                                                                                                                                                                                                                                                              | 2,667                                                                                                                                                                                                                     |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Stock      issued for compensation to employees                                  | 24,725                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                                             | 935,067                                                                                                                                                                                                                   |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Stock      issued for services rendered by consultants                           | 662,520                                                                                                                                                                                                                                                                  | 1,576,673                                                                                                                                                                                                                                                                                        | 3,973,734                                                                                                                                                                                                                 |   |
|   | Stock      issued for prepaid expenses                                           | 300,000                                                                                                                                                                                                                                                                  |                                                                                                                                                                                                                                                                                             | 300,000                                                                                                                                                                                                                   |   |
|   | Stock      issued for interest                                                   | 62,862                                                                                                                                                                                                                                                                   | 38,576                                                                                                                                                                                                                                                                                           | 101,430                                                                                                                                                                                                                   |   |
|   | Changes      in operating assets and liabilities:                                |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | (Increase)      decrease in receivables                                          |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | (Increase)      decrease in prepaid expenses                                     | (284,140)                                                                                                                                                                                                                                                                | (37,960)                                                                                                                                                                                                                                                                                         | (333,398)                                                                                                                                                                                                                 |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Increase      (Decrease) in Accounts Payable                                     | 137,403                                                                                                                                                                                                                                                                  | 80,959                                                                                                                                                                                                                                                                                           | 227,377                                                                                                                                                                                                                   |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Increase      (Decrease) in Accrued Expenses                                     | 221,634                                                                                                                                                                                                                                                                  | 189,282                                                                                                                                                                                                                                                                                          | 485,902                                                                                                                                                                                                                   |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Increase      (Decrease) in Other Comprehensive Income                           | (50,000)                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                                             | (50,000)                                                                                                                                                                                                                  |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Loss      attributable to Non Controlling interest in subsidiary                 | (93,995)                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                                             | (93,995)                                                                                                                                                                                                                  |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Net      Cash Provided by (Used in) Operating Activities                         | (1,506,956)                                                                                                                                                                                                                                                              | (1,234,091)                                                                                                                                                                                                                                                                                      | (4,895,196)                                                                                                                                                                                                               |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | CASH      FLOWS FROM INVESTING ACTIVITIES                                        |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | (      Increase) Decrease in Deposits                                            | (4,200)                                                                                                                                                                                                                                                                  | 1,785                                                                                                                                                                                                                                                                                            | (25,507)                                                                                                                                                                                                                  |   |
|   | Purchases      of fixed assets                                                   |                                                                                                                                                                                                                                                                     | (173,998)                                                                                                                                                                                                                                                                                        | (541,536)                                                                                                                                                                                                                 |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | (Additions)      Decreases  to Securities Available for Sale           | 550,000                                                                                                                                                                                                                                                                  | (500,000)                                                                                                                                                                                                                                                                                        | 50,000                                                                                                                                                                                                                    |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Net      Cash Provided by (Used in) Investing Activities                         | 545,800                                                                                                                                                                                                                                                                  | (672,213)                                                                                                                                                                                                                                                                                        | (517,043)                                                                                                                                                                                                                 |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | CASH      FLOWS FROM FINANCING ACTIVITIES                                        |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Preferred      Stock issued for cash                                             | 57                                                                                                                                                                                                                                                                       | 282                                                                                                                                                                                                                                                                                              | 339                                                                                                                                                                                                                       |   |
|   | Common      stock issued for cash                                                | 158                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                             | 1,630                                                                                                                                                                                                                     |   |
|   | Common      Stock issued for Debt                                                | 216,716                                                                                                                                                                                                                                                                  |                                                                                                                                                                                                                                                                                             | 216,716                                                                                                                                                                                                                   |   |
|   | Common      Stock issued for Accrued Salaries                                    | 120,000                                                                                                                                                                                                                                                                  |                                                                                                                                                                                                                                                                                             | 120,000                                                                                                                                                                                                                   |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Additional      paid in Capital                                                  | 347,701                                                                                                                                                                                                                                                                  | 808,603                                                                                                                                                                                                                                                                                          | 1,675,919                                                                                                                                                                                                                 |   |
|   | Principal      borrowings on notes and Convertible Debentures                    | 285,863                                                                                                                                                                                                                                                                  | 69,851                                                                                                                                                                                                                                                                                           | 1,216,778                                                                                                                                                                                                                 |   |
|   | Increase      (Decrease) Due to Shareholder                                      |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Convertible      notes                                                           |                                                                                                                                                                                                                                                                     | 503,400                                                                                                                                                                                                                                                                                          | 503,400                                                                                                                                                                                                                   |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Contributed      Capital                                                         | 499,000                                                                                                                                                                                                                                                                  |                                                                                                                                                                                                                                                                                             | 499,000                                                                                                                                                                                                                   |   |
|   | Increase      (Decrease) in Bank Overdraft                                       |                                                                                                                                                                                                                                                                     | (11,534)                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Net      borrowings from related parties                                         |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             | 1,195,196                                                                                                                                                                                                                 |   |
|   | Increase      (Decrease) in Notes from Affiliated party                          | (499,000)                                                                                                                                                                                                                                                                | 500,000                                                                                                                                                                                                                                                                                          | 1,000                                                                                                                                                                                                                     |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Net      Cash Provided by (Used in) Financing Activities                         | 970,495                                                                                                                                                                                                                                                                  | 1,870,602                                                                                                                                                                                                                                                                                        | 5,429,978                                                                                                                                                                                                                 |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Net      Increase (Decrease) in Cash                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             | 9,339                                                                                                                                                                                                                                                                    | (35,702)                                                                                                                                                                                                                                                                                         | 17,750                                                                                                                                                                                                                    |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Cash      at Beginning of Period                                                 | 8,410                                                                                                                                                                                                                                                                    | 44,410                                                                                                                                                                                                                                                                                           | 0                                                                                                                                                                                                                         |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Cash      at End of Period                                                       | 17,750                                                                                                                                                                                                                                                                   | 8,410                                                                                                                                                                                                                                                                                            | 17,750                                                                                                                                                                                                                    |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Supplemental  Cash      Flow Disclosures:                              |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Significant      non-cash activities:                                            |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | Stock      issued to cancel debt                                                 |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             | 2,044,592                                                                                                                                                                                                                 |   |
|   | Preferred      stock issued for stock dividend                                   |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             | 108                                                                                                                                                                                                                       |   |
|   | Total                                                                            |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             | 2,044,700                                                                                                                                                                                                                 |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   | The      Following Notes are an integral part of these Financial      Statements |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             | 17,939                                                                                                                                                                                                                    |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             | (17,750)                                                                                                                                                                                                                  |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             | 189                                                                                                                                                                                                                       |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |
|   |                                                                             |                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                      |   |

----

----

----

----

| Acquisition      cost:             | Estimate      useful life (year) |   |   |   |
|------------------------------------|----------------------------------|--------|--------|--------|
| Production      Equipment          | 3      to 5                      |   | $      | US     | 241,884 |   |
| Production      Clean room         | 10                               |   |   |   | 78,264 |   |
| Leasehold      improvement         | 10                               |   |   |   | 197,934 |   |
| Office      equipment              | 3      to 5                      |   |   |   | 7,250 |   |
| Computer                           | 3                                |   |   |   | 16,204 |   |
|                               |                             |   |   |   |   |   |
| Subtotal                           |                             |   |   |   | 541,536 |   |
| Less      accumulated depreciation |                             |   |   |   | (2,668 | )  |
| Total                              |                             |   | $      | US     | 538,868 |   |

----

| As      of September 30 ,2009         |
|---------------------------------------|
|                                  |   |   |   |
| Deferred      tax assets:             |   |   |   |
| Net      operating tax carry forwards |   | $ | 3,596,041 |   |
| Other                                 |   |   | -0- |   |
| Gross      deferred tax assets        |   |   | 3,596,041 |   |
| Valuation      allowance              |   |   | (3,596,041) |   |
|                                  |   |   |   |   |
| Net      deferred tax assets          |   | $ | -0- |   |

----

----

----

----

|   | a) | $10,000      was applied to satisfy  consideration  due to the      Company from Entest in connection with the Company providing to Entest the      services of Dr. Brian Koos |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | b) | 90,000      will be applied to rental payments due to the Company over the course a      sublease agreement between the Company and  Entest.                                                       |

|   | a) | may      not be transferred or hypothecated until  the expiration of a      six month period from the issuance date (“Vesting Date”)    and |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | b) | is      subject to forfeiture in the event that Koos shall cease serving as      Chief Executive Officer of Entest prior to the Vesting  Date                |

|   | Ending      September 30 |   | Amounts |    |
|--------|--------------------------|--------|---------|---------|
|   | 2008                     |   | $       | 241,611 |   |
|   | 2009                     |   |    | 248,864 |   |
|   | 2010                     |   |    | 234,377 |   |
|   | 2011                     |   |    | 42,614  |   |
|   | Total                    |   | $       | 767,466 |   |

----

----

| Flow      Cytometer (4 Color) (BD Facscanto)                          |
|-----------------------------------------------------------------------|
| Laboratory      computer system/also for enrollments/storage tracking |
| Hematology      Analyzer (celldyne 1800)(ABBOTT)                      |
| Laminar      Flow Hood 4 ft ( Clean hood) (2)                         |
| Bench      top centrifuges (2) refrigerated                           |
| Small      equipment (lab set-up)                                     |
| Microscope                                                            |
| Tube      heat sealers (2 ea)                                         |
| Barcode      printer and labeling device                              |

----

----

| (a)   | During      the Company’s two most recent fiscal years and any subsequent interim      period preceding such resignation, declination or dismissal there were no      disagreements with the former accountant on any matter of accounting      principles or practices, financial statement disclosure, or auditing scope      or procedure, which disagreement(s), if not resolved to the satisfaction      of the former accountant, would have caused it to make reference to the      subject matter of the disagreement(s) in connection with its      report. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (b)   | There      was no  reportable event as described in paragraph (a)(1)(v)      of  Item 304 of RegulationS-K |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------|

----

| Position:                                                                                                                 | Company      Name:                                                                                                                                                     | Employment      Dates:                                                                                                              |
|---------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|
| Chairman      , President, Chief Executive Officer, Secretary, Chief Financial Officer,      Principal Accounting Officer |        Entest Biomedical, Inc.(a      Nevada corporation majority owned by the Company which owns 100% of Entest      biomedical, Inc., a California corporation) |  June      19, 2009 to the present.                                                                                            |
| Chairman,      President, CEO and Acting CFO                                                                              | Bio-Matrix      Scientific Group, Inc.                                                                                                                            | June      14, 2006 (Chairman) to PresentJune      19, 2006 (President, CEO and Acting CFO)June      19, 2006 (Secretary) to Present |
| Chairman      CEO, President, Secretary, and Acting CFO                                                                   | Entest      Biomedical, Inc (a California corporation)                                                                                                                 | August      22, 2008 to the Present                                                                                                 |
| Chairman,      CEO, Secretary & Acting CFO                                                                            |  Frezer      Inc.                                                                                                                                                 | May      2, 2005 to February 2007                                                                                              |
| Chairman,      CEO & Acting CFO                                                                                       |  BMXP      Holdings, Inc.                                                                                                                                    | December      6, 2004 to June 2008                                                                                                  |
| Managing      Director & President                                                                                    | Cell      Source Research Inc.                                                                                                                                         | December      5, 2001 to Present                                                                                                    |
| Managing      Director & President                                                                                    | Venture      Bridge Inc.                                                                                                                                               | November      21, 2001 to Present                                                                                                   |
| Chairman      of the Board of Directors, CFO & Secretary                                                              | Cell      Bio-Systems Inc.(New      York)                                                                                                                              | July      17, 2003 to December 1, 2003                                                                                              |
| Registered      Representative                                                                                            | Amerivet      Securities Inc.*                                                                                                                                         | March      31, 2004 to February 2008                                                                                                |

----

----

| SUMMARY      COMPENSATION TABLE                                         |
|-------------------------------------------------------------------------|
| Name      and Principal Position                                   | Year  | Salary($)  | Bonus($)  | StockAwards($)  | OptionAwards($)  | Non      EquityIncentivePlanCompensation($)  | NonqualifiedDeferredCompensationEarnings($)  | AllOtherCompensation($)  | Total($)  |
| David      KoosChairman      and CEO                                    |  From      October 1, 2008 to September 30, 2009 |  18,000** |  0 |  320,000*** |   |   |   |   |  338,000 |
| David      KoosChairman      and CEO                                    |  From      October 1, 2007 to September 30, 2008 |  7,500 |  0 |   |   |   |   |   | 7,500 |
| Brian      PockettVice      President,COO      and  Director* |  From      October 1, 2008 to September 30, 2009 |  56,000 |   |   |   |   |   |   | 56,000 |
| Brian      PockettVice      President,COO      and  Director  | From      October 1, 2007 to September 30, 2008 | 86,200 |   |   |   |   |   |   | 86,200 |

----

| Title      of Class | Name      and Address of Beneficial Owner                                                          | Amount      and Nature of Beneficial Owner | Percent      of Class |
|---------------------|----------------------------------------------------------------------------------------------------|--------------------------------------------|-----------------------|
| Common              | David      R. KoosC/o      Bio-Matrix Scientific Group, Inc8885      REHCO RD, SAN DIEGO, CA 92121 | 4,670,377(a)                               | 9%                    |
| Common              | All      Officers and DirectorsAs      a Group(a)                                                  | 4,670,377(a)                               | 9%                    |

| Title      of Class | Name      and Address of Beneficial Owner                                                                                                                                                                                                                                                                                                                                          | Amount      and Nature of Beneficial Owner | Percent      of Class |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------|-----------------------|
| Preferred           | David      R. Koos (a)(b)C/o      Bio-Matrix Scientific Group, Inc8885      REHCO RD. SAN DIEGO CA 92121                                                                                                                                                                                                                                                                           | 523,      809                              | 17%                   |
| Preferred           | Copeland      Revocable Trust                                                                                                                                                                                                                                                                                                                                                      | 166,907                                    | 5.6%                  |
| Preferred           |  Ronald      Williams                                                                                                                                                                                                                                                                                                                                                         | 205,714                                    | 6.9%                  |
| Preferred           | All      Officers and DirectorsAs      a Group(c)                                                                                                                                                                                                                                                                                                                                  | 523,809                                    | 17%                   |
|                |                                                                                                                                                                                                                                                                                                                                                                               |
| (a)                 | Includes      458,503 Preferred  Shares owned by BMXP Holdings Shareholder      Business Trust.  David R. Koos is the Trustee of BMXP Holdings      Shareholder Business Trust. (b) Includes shares owned by Bombardier      Pacific Ventures Inc., which is wholly owned by David Koos and AFN      Trust for which David Koos serves as  Trustee . |

----

| Title      of Class     | Name      and Address of Beneficial Owner                                                                                                                                                                                                                                                                                                                               | Amount      and Nature of Beneficial Owner | Percent      of Class |
|-------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------|-----------------------|
| Series      B Preferred | David      R. Koos (a)(b)C/o      Bio-Matrix Scientific Group, Inc8885      REHCO RD, SAN DIEGO, CA 92121                                                                                                                                                                                                                                                               | 96,012                                     | 13%                   |
| Series      BPreferred  | All      Officers and DirectorsAs      a Group(c)                                                                                                                                                                                                                                                                                                                       | 96,012                                     | 17%                   |
|                    |                                                                                                                                                                                                                                                                                                                                                                    |
| (a)                     | Includes      9,171 Preferred Shares owned by BMXP Holdings Shareholder Business      Trust.  David R. Koos is the Trustee of BMXP Holdings      Shareholder Business Trust. (b) Includes shares owned by Bombardier      Pacific Ventures Inc., which is wholly owned by David Koos  and      AFN Trust for which David Koos serves asTrustee |

| Title      of Class      | Name      and Address of Beneficial Owner                                                          | Amount      and Nature of Beneficial Owner | Percent      of Class |
|--------------------------|----------------------------------------------------------------------------------------------------|--------------------------------------------|-----------------------|
| Series      AA Preferred | David      R. KoosC/o      Bio-Matrix Scientific Group, Inc8885      REHCO RD, SAN DIEGO, CA 92121 | 4,852                                      | 100%                  |
| Common                   | All      Officers and DirectorsAs      a Group(a)                                                  | 4,852                                      | 100%                  |

----

|   | (a) | $10,000      was applied to satisfy consideration due to us from the      Entest  in connection with  us providing to Entest the      services if Dr. Brian Koos |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | (b) | $90,000      will be applied to rental payments due to us over the course of the      aforementioned sublease agreement between us and Entest    Bio.                                |

----

|                    |   | Period      beginningOct      1, 2007 andending      September30,      2008 |         |
|-------------------------|--------|-----------------------------------------------------------------------------|--------------|
|                    |   |                                                                        |         |
| Audit      Fees         |   | $                                                                           |  15,000 |   |
| Audit      Related Fees |   | $                                                                           | 16,500       |   |
| Tax      Fees           |   |                                                                        |         |   |
| All      Other Fees     |   |                                                                        |         |   |
|                    |   |                                                                        |         |   |
|                    |   | $                                                                           | 31,500       |   |

----

|                    |   | Period      beginningOct      1, 2008 andending      September30,      2009 |
|-------------------------|--------|-----------------------------------------------------------------------------|
|                    |   |                                                                        |
| Audit      Fees         |   | $                                                                           |  9,000 |
| Audit      Related Fees |   | $                                                                           | 6,000 |
| Tax      Fees           |   |                                                                        |   |
| All      Other Fees     |   |                                                                        |   |
|                    |   |                                                                        |   |
|                    |   | $                                                                           | 15,000 |

|                    |   | Period      beginningOct      1, 2008 andending      September30,      2009 |
|-------------------------|--------|-----------------------------------------------------------------------------|
|                    |   |                                                                        |
| Audit      Fees         |   |                                                                        |   |
| Audit      Related Fees |   | $                                                                      | 3,000 |
| Tax      Fees           |   |                                                                        |   |
| All      Other Fees     |   |                                                                        |   |
|                    |   |                                                                        |   |
|                    |   | $                                                                           | 3,000 |

----

----

| EXHIBITNUMBER |   | DESCRIPTION                                                         |
|---------------|--------|--------------------------------------------------------------------------|
|          |   |                                                                     |
| 31.1          |   | CERTIFICATION      BY CEO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT  |
| 32.1          |   | CERTIFICATION      BY CEO PURSUANT TO SECTION 906 OF SARBANES OXLEY ACT  |
| 31.2          |   | CERTIFICATION      BY CEO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT  |
| 32.2          |   | CERTIFICATION      BY CFO PURSUANT TO SECTION 906 OF SARBANES OXLEY  ACT |

|   |   |   |   |                                                                                                    |
|--------|--------|--------|--------|---------------------------------------------------------------------------------------------------------|
|   |   |   |   | Bio-Matrix      Scientific group, inc.                                                                  |
|   |   |   |   |                                                                                                    |
|   |   | By:    |   | /s/  David R.  Koos                                                                           |
|   |   |   |   | Name:      David R. Koos                                                                                |
|   |   |   |   | Title:  Chairman,      ChiefExecutive      Officer, President, Acting Chief Financial Officer |
|   |   |   |   | Date:      January 13, 2010                                                                             |

----